References
- Hawking F. Suramin: with special reference to onchocerciasis. Adv Pharm Chemother 1978; 101: 289
- Coffey R, Leof E, Shipley G. Suramin inhibition of growth factor recepter binding and mitogenicity in ARK-2 B cell. J Cell Phys 1987; 132: 143–8
- Danesi R, La Rocca R V, Stein C A, Neckers L, Myers CE. Effect of suramin on the human glioma cell line U706T. Proc AACR 1989; 30: 578
- Ewing M W, La Rocca R V, Stein C A, Myers C E, Linehan WM. Effect of suramin on proliferation of human prostate carcinoma. Proc AACR 1989; 30: 310
- Clark J, Chu M, Calabresi P. Growth inhibition of colon cancer cells by oenistein and suramin. Proc AACR 1989; 30: 557
- Fujiuchi S, Tsuji T, Ohsaki Y, Kikuchi K. The effect of suramin on human lung cancer cell line in vitro. Jpn J Cancer Chemother 1994; 21: 647–52
- Allan T, Van O. Suramin for prostatic cancer: a phase WI study in advanced extensively pretreated disease. Eur J. Cancer 1990; 26: 422
- Yasui W, Yoshida K, Tahara E. Growth factors in human gastrointestinal carcinomas. Protein Nucl Acid Enzyme 1991; 36: 1371–8
- Maeda Y, Hayashi Y, Koike M. Establishment of the nude mice xenograft and cell line (KEsC-I) of human esophageal carcinoma producing carcinoembryonic antigen. Igakunoayumi 1990; 153: 591–2
- Carmichel J, De Graff W G, Gazdar A F, Minna J D, Mitchell JB. Evaluation of tetrazolium-based semi-automated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987; 47: 936–41
- Heldin C H, Westermark B. Growth factors: mechanism of action and relation to oncogenes. Cell 1984; 37: 9–20
- Sporn M B, Todaro G J. Autocrine and malignant transformation of cells. N Engl J Med 1980; 303: 878–80
- Cross M, Dexter T M. Growth factors in development, transformation, and tumorigenesis. Cell 1991; 64: 271–80
- Olivier S, Formento P, Fischel L, Etienne M C, Milano G. Epidermal growth factor receptor expression and suramin cytotoxicity in vitro. Eur J. Cancer 1990; 26: 867–71
- Yarden Y, Ullrich A. Growth factor receptor tyrosine kinases. Ann Rev Biochem 1988; 57: 443–78
- Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990; 61: 203–12
- Massimo C, Oliver S, Keith CR. Suramin, an experimental chemotherapeutic drug, activates the receptor for epidermal growth factor and promotes growth of certain malignant cells. J Clin Invest 1992; 89: 1242–7
- Murayama Y. Growth-inhibitory effects of epidermal growth factor on human breast cancer and carcinoma of the esophagus transplanted into nude mice. Ann Surg 1990; 3: 263–8